Sham procedure: Clinical Trials

149 trials of Sham procedure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

84 completed, 17 terminated, 17 unknown, 15 recruiting. 78 Not applicable, 40 Phase 3, 28 Phase 2, 8 Phase 1, 4 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable78Completed 37, Unknown 13, Terminated 9, Recruiting 7, Active not recruiting 5, Not yet recruiting 3, Withdrawn 3, Enrolling by invitation 1
Phase 340Completed 23, Terminated 7, Recruiting 5, Unknown 3, Active not recruiting 1, Not yet recruiting 1
Phase 228Completed 18, Active not recruiting 3, Recruiting 3, Terminated 2, Unknown 2
Phase 18Completed 5, Active not recruiting 2, Recruiting 1
Phase 44Completed 3, Recruiting 1

Follow Sham procedure: new trials by email Literature Review of Sham procedure trials Research Report on Sham procedure

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection Fraction
PADN, Sham procedure, GDMT - Heart Failure With Preserved Ejection Fraction
Not applicableNot yet recruitingNanjing First Hospital, Nanjing Medical University3102026-12-302026-05-27
A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
Salanersen, Sham Procedure - Muscular Atrophy, Spinal
Phase 3RecruitingBiogen422026-10-312026-10-15
Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
Dehydrated Alcohol Injection, USP, Sham procedure - Hypertension, Hypertension,Essential
Phase 3Not yet recruitingAblative Solutions, Inc.2022026-10-012026-08-20
BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.
rugonersen, Sham procedure - Angelman Syndrome
Phase 3RecruitingOHB Pediatrics Ltd.1652026-06-232026-10-20
SII Levels Following PENG Block in Pediatric Hip Surgery
Ropivacaine 0.2% Injectable Solution, 0.9%NaCl - Hip Dysplasia
Not applicableNot yet recruitingPoznan University of Medical Sciences1002026-06-012026-05-26
The Effect of Spinal Manipulation on Heart Rate Variability in Children With Cerebral Palsy.
Spinal manipulation, Sham Procedure - Cerebral Palsy (CP)
Not applicableRecruitingInternational Clinic of Rehabilitation, Ukraine202026-05-012026-05-29
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Gen 2 Travoprost Intracameral Implant, Timolol eye drops 0.5%, Sham Procedure - Glaucoma
Phase 3RecruitingGlaukos Corporation5102026-02-172026-03-30
External Oblique Intercostal Plane Block for Liver Transplantation Recipient
External Oblique Intercostal Plane Block, Sham Procedure - Liver Transplantation, Recipients of Liver Transplant
Not applicableCompletedIstinye University642025-12-222026-06-25
Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease
Pulse electric field ablation system, Sham Procedure - Chronic Bronchitis, COPD (Chronic Obstructive Pulmonary Disease)
Not applicableRecruitingSuzhou Hengruihongyuan Medical Technology Co. LTD2102025-09-012025-09-02
EuroNetrod HTN OFF-Med Study of Renal Denervation With NetrodTM Six-electrode Radiofrequency RDN System
Netrod™ six-electrode radiofrequency renal denervation system, Sham Procedure - Uncontrolled Hypertension
Not applicableWithdrawnShanghai Golden Leaf MedTec Co. Ltd2025-08-302025-07-31
Efficacy and Safety of Cold Atmospheric Plasma Combined With Endovascular Intervention in Patients With Diabetic Foot Ulcers and Lower Extremity Arterial Occlusion
Cold atmospheric plasma (CAP), Sham Procedure, Successful infrapopliteal angioplasty - Diabetic Foot Ulcers (DFU), Lower Extremity Arterial Occlusion
Not applicableRecruitingShenyang Medical College862025-07-222026-01-30
Serratus Posterior Superior Intercostal Plane Block in Cardiac Implantable Electronic Device Implantation
SPSIP Block, Sham procedure - Pain, Postoperative
Not applicableCompletedGozde Altun602025-06-302026-06-11
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Gen 2 Travoprost Intracameral Implant, Timolol eye drops 0.5%, Sham Procedure - Glaucoma
Phase 2RecruitingGlaukos Corporation1102025-06-122026-09-17
Erector Spinae Plane Block for Acute Back Pain in the Emergency Department
Erector Spinae Plane Block, Sham Procedure - Low Back Pain
Not applicableRecruitingRush University Medical Center622025-02-032026-03-12
Trans-nasal Sphenopalatine Ganglion Block for Prevention of Emergence Agitation Following Functional Endoscopic Sinus Surgery
Bilateral Trans-nasal Sphenopalatine Ganglion Block, Sham Trans-nasal Injection - Chronic Rhinosinusitis (CRS), Emergence Agitation
Not applicableCompletedMansoura University1002025-01-052026-06-12
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)
ION440, Sham procedure - Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Phase 1 / Phase 2RecruitingIonis Pharmaceuticals, Inc.482024-10-212026-10-08
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
JNJ-81201887, Sham Procedure - Geographic Atrophy, Macular Degeneration
Phase 2 / Phase 3RecruitingJanssen Research & Development, LLC2742024-09-192026-09-30
Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients
Revita® DMR Treatment, Sham procedure - Diabetes Mellitus, Type 2
Not applicableActive not recruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)182024-08-092026-08-06
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
Endogenex Treatment, Sham Procedure - Type 2 Diabetes Mellitus, Type2diabetes
Not applicableActive not recruitingEndogenex, Inc.3502024-05-012026-08-05
A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)
KUS121 high dose, KUS121 low dose, Sham procedure - Central Retinal Artery Occlusion
Phase 2CompletedKyoto Drug Discovery and Development Co., Ltd.172024-04-162026-02-18

Showing 20 of 149. Sign in to see all of them.

Conditions studied

Hypertension (10)  ·  Macular Degeneration (9)  ·  Eye Diseases (6)  ·  Macular Edema (6)  ·  Retinal Diseases (6)  ·  Vision Disorders (6)  ·  Diabetes Mellitus, Type 2 (5)  ·  Gastroesophageal Reflux (5)  ·  Geographic Atrophy (5)  ·  Glaucoma, Open-Angle (5)  ·  Obesity (5)  ·  Retinal Degeneration (5)  ·  Vascular Diseases (5)  ·  Vision, Low (5)  ·  Essential Hypertension (4)

Sponsors

Hoffmann-La Roche (13)  ·  Allergan (5)  ·  Kodiak Sciences Inc (5)  ·  Biogen (4)  ·  Apellis Pharmaceuticals, Inc. (3)  ·  Glaukos Corporation (3)  ·  Nantes University Hospital (3)  ·  University of Sao Paulo (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  Clearside Biomedical, Inc. (2)  ·  Elisabeth-TweeSteden Ziekenhuis (2)  ·  EndoGastric Solutions (2)  ·  Intersect ENT (2)  ·  Janssen Research & Development, LLC (2)  ·  Mansoura University (2)

Countries

United States (87)  ·  Germany (29)  ·  France (26)  ·  Italy (25)  ·  Spain (23)  ·  United Kingdom (23)  ·  Poland (21)  ·  Australia (20)  ·  Canada (19)  ·  Brazil (15)  ·  Netherlands (15)  ·  Czechia (14)  ·  Hungary (14)  ·  Israel (14)  ·  China (13)

Top investigators

Pablo Velazquez-Martin, MD (5)  ·  David Kandzari, MD (3)  ·  Joanne Li (2)  ·  Kazuomi Kario, MD (2)  ·  Raymond Townsend, MD (2)  ·  Ajay J Kirtane, M.D (1)  ·  Amir Mostafa Shabana, MD (1)  ·  Andrew Charles, MD (1)  ·  Andrew Sharp, Prof. (1)  ·  Anita P. Courcoulas, MD MPH FACS (1)

Results publications

PMID 37314061, PMID 39526682, PMID 41534798, PMID 26699604, PMID 31420846, PMID 32034481, PMID 35085502, PMID 35085503, PMID 36246184, PMID 36246941, PMID 36787524, PMID 36897413, PMID 37294433, PMID 37585454, PMID 37865470, PMID 38158159, PMID 38280653, PMID 38382813, PMID 38722644, PMID 38758639, PMID 38814626, PMID 38852921, PMID 40388106, PMID 40668667, PMID 41712218, PMID 42753135, PMID 42771326, PMID 10379020, PMID 15713907, PMID 21466679, PMID 21768318, PMID 23442554, PMID 24554030, PMID 24884948, PMID 25448925, PMID 25808980, PMID 25824248, PMID 25872590, PMID 26992115, PMID 27939059, PMID 28000425, PMID 28859944, PMID 29091570, PMID 29191325, PMID 29420232, PMID 29443664, PMID 29743284, PMID 29803589, PMID 29803590, PMID 30392080

NIH funding

2014 (4), 2017 (3), 2018 (2), 2023 (2), 2019 (1), 2025 (1), M01RR000070 (1), M01RR000750 (1), M01RR000997 (1), M01RR006022 (1), M01RR008084 (1), P30AG064198 (1), U01HD019897 (1), U10HD021364 (1), U10HD021373 (1)